For example, copy number amplification of HSPA2 was associated with its increased expression in breast cancer, glioblastoma multiforme, head and neck squamous carcinoma, lung squamous cell carcinoma, uterine corpus endometrial carcinoma and ovarian serous cystadenocarcinoma (Table 5). Here, HSPA2 is linked to breast carcinoma.